Chargement en cours...
The benefit of combination therapy depends on disease phenotype and duration in Crohn’s disease
INTRODUCTION: The impact of combination therapy on disease-related morbidity in patients with established Crohn’s disease (CD) or ulcerative colitis (UC) remains to be well-defined. AIM: To examine the effect of combination therapy on disease outcomes in CD and UC METHODS: Using a multi-center prosp...
Enregistré dans:
| Publié dans: | Aliment Pharmacol Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5484085/ https://ncbi.nlm.nih.gov/pubmed/28470787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14125 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|